Top Story

Antibody vaccine for treatment of type 1 diabetes enters preclinical trial

October 22, 2016

Neovac, a French company specializing in immunotherapies, will begin studying its interferon-alpha kinoid vaccine for the treatment of type 1 diabetes in collaboration with French researchers at the Cochin Hospital in Paris, according to a company press release

IFN-alpha kinoid produces polyclonal neutralizing antibodies to interrupt IFN-alpha. Overexpression of this protein is a signature of type 1 diabetes.
whether the neutralizing antibodies are effective on IFN-alpha.

Top 5 online thyroid stories posted in the last month

October 21, 2016
Endocrine Today has compiled a list of the top five news reports on the thyroid posted from Sept. 20 to Oct. 20. Healio.com/Endocrinology readers were interested in…
In the Journals Plus

Timing of daily walks improves glycemic profile in type 2 diabetes

October 21, 2016
Adults with type 2 diabetes saw lower postprandial blood glucose when they took three daily 10-minute walks after meals vs. when they took daily 30-minute walks at…
In the Journals Plus

With physical activity, ‘some is good but more is better’ for preventing type 2 diabetes

October 21, 2016
When it comes to physical activity, there is no clear cutoff point at which benefits are not achieved, but the risk for developing type 2 diabetes continues to decrease…
In the Journals Plus

Glucose challenge test accurate, convenient in primary care setting

October 21, 2016
Glucose challenge test screening, paired with oral glucose tolerance testing where appropriate, is less expensive and more accurate than other opportunistic tests for
More News Headlines »
CME Video

Secondary Prevention of Atherothrombotic Events: Current Insights on Advancing Science

This activity is supported by an educational grant from Merck & Co.

Prevention of cardiovascular disease (CVD) is critical in light of its associated mortality, morbidity, and economic…
More »
Meeting News Coverage

VIDEO: Noninvasive follicular thyroid neoplasms cause little risk for patients

September 23, 2016
More »
Cardiometabolic Health Congress

Cardiometabolic Health Congress


Diabetic Retinopathy: Preferred Practice Patterns in Screening and Management

This activity is supported by an educational grant from Regeneron.

Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence…
More »
Current Issues
View the Current Issues